Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 5/20 | 0.56 |
| ▸ | ADH1C | P00326 | 3/20 | 0.56 |
| ▸ | ADH1B | P00325 | 1/20 | 0.56 |
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | PHGDH | O43175 | 2/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12250816 | 1.00 | ADH1A (0.56) | ADH1AADH1CADH1BFDPSPHGDH | |
| SCHEMBL12250814 | 1.00 | ADH1A (0.56) | ADH1AADH1CADH1BFDPSPHGDH | |
| Water SCHEMBL5051038 | 0.97 | ADH1A (0.54) | ADH1AADH1CADH1BFDPSPHGDH | |
| SCHEMBL12250815 | 0.97 | ADH1A (0.54) | ADH1AADH1CADH1BFDPSPHGDH | |
| SCHEMBL25075545 | 0.91 | ADH1A (0.46) | ADH1AADH1CADH1BFDPS | |
| SCHEMBL27097597 | 0.88 | ADH1C (0.47) | ADH1AADH1CADH1BFDPS | |
| SCHEMBL9963391 | 0.84 | ADH1B (0.39) | ADH1AADH1CADH1B | |
| SCHEMBL18841464 | 0.79 | ADH1A (0.52) | ADH1AADH1CADH1BFDPSPHGDH | |
| SCHEMBL9551174 | 0.79 | ADH1A (0.52) | ADH1AADH1CADH1BFDPSPHGDH | |
| SCHEMBL296264 | 0.79 | ADH1A (0.52) | ADH1AADH1CADH1BFDPSPHGDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105503946-B | The manufacturing method of hydroxymethyl phosphonic acid ester, polyurethane foam formation composition, polyurethane foam and the product being made from it | ICL-IP美国公司 | 2018-10-12 | — | — | CN | claimed |
| CN-105503946-A | Method for making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP America Inc | 2016-04-20 | — | — | CN | claimed |
| CN-102256987-B | Hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foams, and methods of making articles made therefrom | ICL-IP AMERICA INC. (US) | 2016-01-13 | — | — | CN | claimed |
| US-9187504-B2 | Method of making hydroxymethylphosphonate | ICL-IP AMERICA INC. (US) | 2015-11-17 | — | — | US | claimed |
| EP-2376507-B1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATES | ICL IP AMERICA INC (US) | 2013-05-15 | — | — | EP | claimed |
| US-8198341-B2 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP AMERICA INC. (US) | 2012-06-12 | — | — | US | claimed |
| CN-102256987-A | Hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foams, and methods of making articles made therefrom | ICL IP AMERICAN CORP | 2011-11-23 | — | — | CN | claimed |
| US-20110257287-A1 | Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom | STOWELL JEFFREY K | 2011-10-20 | — | — | US | claimed |
| EP-2376507-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM | ICL-IP America Inc. (US) | 2011-10-19 | — | — | EP | claimed |
| WO-2010080425-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM | SUPRESTA LLC. (US) | 2010-07-15 | — | — | WO | claimed |
| US-20100160468-A1 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP AMERICA INC. | 2010-06-24 | — | — | US | claimed |
| WO-2008033229-A2 | A METHOD OF MAKING POROUS CRYSTALLINE MATERIALS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2008-03-20 | — | — | WO | claimed |
| US-20230276701-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMISSION DEVICE | OSAKA UNIVERSITY (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | NATIONAL INSTITUTES OF HEALTH | 2023-05-11 | — | — | US | disclosed |
| CN-115703855-A | Catalyst system for C4 liquefied petroleum gas cationic polymerization and polybutene production method | 南京中科康润新材料科技有限公司 | 2023-02-17 | — | — | CN | disclosed |
| WO-2023016561-A1 | CATALYST SYSTEM FOR CATIONIC POLYMERIZATION OF C4 LIQUEFIED PETROLEUM GAS AND POLYBUTYLENE PRODUCTION METHOD | 南京中科康润新材料科技有限公司 | 2023-02-16 | — | — | WO | disclosed |
| WO-2008033229-A2 | A METHOD OF MAKING POROUS CRYSTALLINE MATERIALS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2008-03-20 | — | — | WO | disclosed |
| US-20070249678-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | PRODIMED, S.A. (ES) | 2007-10-25 | — | — | US | disclosed |
| EP-0382053-B1 | PROCESS FOR THE PREPARATION OF ANTHRAQUINONE DERIVATIVES | BASF Aktiengesellschaft (DE) | 1993-09-22 | — | — | EP | disclosed |
| EP-0382053-A2 | Process for the preparation of anthraquinone derivatives | BASF Aktiengesellschaft (DE) | 1990-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249678-A1 | SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES | GLUL, RIMKLA, PHKG1 | ADH1A 3255/4885ADH1C 4159/4885ADH1B 3779/4885 |
| US-20110257287-A1 | Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom | PFAS, PGM2, NEFM | ADH1A 1854/4885ADH1C 1581/4885ADH1B 3071/4885 |
| US-20100160468-A1 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | PFAS, PGM2, NEFM | ADH1A 1854/4885ADH1C 1581/4885ADH1B 3071/4885 |
| US-20230276701-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMISSION DEVICE | ESR1, ECE1, ESYT1 | ADH1A 3774/4885ADH1C 4606/4885ADH1B 2998/4885 |
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | HAVCR2, CD44, ENGASE | ADH1A 1603/4885ADH1C 3364/4885ADH1B 1643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.